Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goicoechea

Showing results (1011-1020 of 1,028) with videos related to

Pageof 103
Sort By:
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Stroke|March 2, 2026
Recurrent Stroke in Patients With Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) StudyRicha Sharma, Katelyn F McNamara, Elena Badillo Goicoechea, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Current Obesity Reports|October 2, 2024
Mexican Clinical Practice Guidelines for Adult Overweight and Obesity ManagementEmma A Chávez-Manzanera, Juan M Vera-Zertuche, Martha Kaufer-Horwitz, et al.
Nature|June 26, 2023
Formation of the methyl cation by photochemistry in a protoplanetary diskOlivier Berné, Marie-Aline Martin-Drumel, Ilane Schroetter, et al.
Pageof 103

Showing results (1011-1020 of 1,028) with videos related to

Sort By:
Pageof 103
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Blood|July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Stroke|March 2, 2026
Recurrent Stroke in Patients With Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) StudyRicha Sharma, Katelyn F McNamara, Elena Badillo Goicoechea, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Current Obesity Reports|October 2, 2024
Mexican Clinical Practice Guidelines for Adult Overweight and Obesity ManagementEmma A Chávez-Manzanera, Juan M Vera-Zertuche, Martha Kaufer-Horwitz, et al.
Nature|June 26, 2023
Formation of the methyl cation by photochemistry in a protoplanetary diskOlivier Berné, Marie-Aline Martin-Drumel, Ilane Schroetter, et al.
Pageof 103